Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Mark Hallett MD
Mark Hallett MD Editor-in-Chief
Argye Hillis MD, MA
Argye Elizabeth Hillis MD, MA Associate Editor
Nina Schor MD, PhD
Nina F. Schor MD, PhD Advisory Board
See All Experts
featured
Published in Neurology

Journal Scan / Research · August 30, 2016

Safety of Recombinant Tissue Plasminogen Activator in Wake-Up Stroke Promising

Annals of Neurology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Argye Hillis MD, MA

Annals of Neurology
Prospective, Open-Label Safety Study of Intravenous Recombinant Tissue Plasminogen Activator in Wake-Up Stroke
Ann. Neurol 2016 Aug 01;80(2)211-218, AD Barreto, CV Fanale, AV Alexandrov, KC Gaffney, FS Vahidy, CB Nguyen, A Sarraj, M Rahbar, JC Grotta, SI Savitz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated